Trials / Completed
CompletedNCT03846232
Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging
T1rho: Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Barcelonabeta Brain Research Center, Pasqual Maragall Foundation · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
The main goal of the T1rho/BBRC2017 study is to assess the capability of the MRI sequences T1rho + multicomponent T2 relaxation analysis of detecting abnormal cerebral protein deposition in AD patients in comparison with an age-matched cognitively healthy control group. Both the AD and control groups will had previously undergone amyloid PET imaging to confirm/discard cerebral proteinopathy in the context of other research studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2020-11-30
- Completion
- 2022-12-31
- First posted
- 2019-02-19
- Last updated
- 2023-03-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03846232. Inclusion in this directory is not an endorsement.